IL10 and Sepsis: At day 8 after inoculation, surviving mice developed splenomegaly with a significant increase in the spleen mass (Figure 2A) and increased levels of IL-10 in serum, characteristic of the immunosuppressive phase of sepsis, were observed (Figure 2B).